2014
DOI: 10.1177/2047487314560663
|View full text |Cite
|
Sign up to set email alerts
|

Effect of the natural sweetener, steviol glycoside, on cardiovascular risk factors: A systematic review and meta-analysis of randomised clinical trials

Abstract: The evidence from published RCTs suggests that stevioside may generate reductions in blood pressure and fasting blood glucose. The sizes of the effects are small, and the substantial heterogeneity limits the robustness of any conclusions. Rebaudioside A does not appear to have any significant effects on blood pressure or cardiovascular risk factors. Available clinical trials vary in design and reporting quality, and some are characterised by inadequate sample sizes. In addition, the participants in most of the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
21
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 35 publications
(23 citation statements)
references
References 51 publications
2
21
0
Order By: Relevance
“…Several other systematic and narrative reviews have examined the effects of NSSs on various health outcomes 34 5 6 94 95 96 97 The methodological and clinical inclusion and exclusion criteria used in these systematic reviews differed substantially from our criteria in the present study, resulting in a different pool of included studies. The data synthesis methods also differed from the ones used in the present review.…”
Section: Discussionmentioning
confidence: 98%
“…Several other systematic and narrative reviews have examined the effects of NSSs on various health outcomes 34 5 6 94 95 96 97 The methodological and clinical inclusion and exclusion criteria used in these systematic reviews differed substantially from our criteria in the present study, resulting in a different pool of included studies. The data synthesis methods also differed from the ones used in the present review.…”
Section: Discussionmentioning
confidence: 98%
“…on arterial blood pressure in patients with normal and low arterial pressure. Metaanalysis of the existing reports does not confirm significant hypotensive effects of stevia glycosides on systolic blood pressure vs. placebo, while appreciable lowering effects on diastolic blood pressure and blood glucose level have been observed (Onakpoya and Heneghan 2014).…”
Section: Hypotensive Effectmentioning
confidence: 84%
“…Low-calorie sweeteners) postprandial hyperglycemia intervention trials studies in English language ND MEDLINE, Web of Science Shankar, 2013 [ 279 ] ND NNS consumption obesity/weight gain; diabetes; cardiometabolic indicators ND ND 2012 MEDLINE Spencer, 2016 [ 280 ] humans and animals aspartame, saccharin or sucralose consumption fermentation, absorption, gastrointestinal symptoms ND full articles in English language June 2015 MEDLINE, EMBASE Timpe Behnen, 2013 [ 281 ] diabetes patients acesulfame, aspartame,luo han guo, monk fruit, neotame, rebiana, saccharin, stevia, and sucralose diabetic control, including, but not limited to, blood glucose levels, postprandial blood glucose, HbA1c clinical studies studies in English language May 2012 MEDLINE, Scopus Wiebe, 2011 [ 23 ] ND a sweetener (e.g. non-caloric sweetener) weight change, energy intake, lipids, HbA1C, insulin resistance parallel or crossover RCT follow-up at least 1 week in duration; at least 10 participants per group, no trials with placebo control January 2011 MEDLINE, EMBASE, Cochrane Library CENTRAL, CAB Global Oliver, 2015 [ 85 ] ND aspartame, ace-K, cyclamic acid and its salts, steviol glycosides, neohesperidin DC, neotame, saccharine and its salts, sucralose,aspartame-acesulfame salt, thaumatin benefits and risks related to intense sweeteners meta-analysis, RCTs, quasi experimental, cohort, case-control, cross-sectional studies none ND MEDLINE, Cochrane Database of Systematic Reviews, Psychinfo Onakpoya, 2015 [ 21 ] adult volunteers (>18 y) steviol glycoside cardiovascular risk factors (blood pressure, blood sugar, cholesterol) double-blind RCTs No age, language or time restrictions. Studies in which steviol glycosides were combined with other dietary supplements were excluded May 2014 MEDLINE, EMBASE, Amed, Cinahl, Th...…”
Section: Resultsmentioning
confidence: 99%